Atlas Genetics is an innovative UK-based in vitro diagnostics company focussing on decentralised, near-patient and point-of -care (POC) testing. Our aim is to improve patient outcomes by providing clinicians and other healthcare professionals with a simple-to-use, rapid, cost-effective solution to enable on-demand diagnosis of diseases in decentralised settings.
We have developed the ultra-rapid io® diagnostic platform, a platform system consisting of a small, low cost instrument (io® Reader) and test-specific, disposable cartridges (io® Cartridge) providing an accurate, actionable test result in around 30 minutes.
Our initial focus is in the areas of Sexually Transmitted Infections (STI) and Hospital Acquired Infections (HAI) where rapid diagnosis is essential for effective treatment and control.
Atlas Genetics has it's headquarters in the South West of England, close to the World Heritage city of Bath, and US office in Boston, MA.